Paul M. Weiss

Paul M. Weiss is a declared insider at 2 companies; the most frequent names are Alfacell Corp and Whitehawk Therapeutics, Inc. Between 19 October 2007 and 15 March 2017, the trades on record add up to 4 filings.

Purchases make up the whole of the open-market record (4 purchases, €1.3M). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2017 alone, the filings show 1 purchase and no sales.

The median purchase comes to €6,021.

Most recently, on 17 March 2017, the filings show an open-market purchase worth €1.3M in Whitehawk Therapeutics, Inc. Most trades are made public on the day they happen. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.